Therapeutic Effects of Endoscopic Ablation of Hunner Lesions in Interstitial Cystitis/ Bladder Pain Syndrome Patients

Status: Completed
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

efficacy of endoscopic ablation of Hunner lesions in patients with IC/BPS and the characteristics of HLs based on a long-term follow-up

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Male and female aged 18 yrs or greater

• Patients diagnosed with BPS(Bladder Pain Syndrome)

• Symptom persisted more than 6 months

• Pain VAS ≥4

• O'Leary-Sant Interstitial Cystitis questionnaire (IC-Q) scores 12 or greater with pain and nocturia domain scores \> 2.

• Pelvic Pain and Urgency/Frequency Patient Symptom Scale(PUF) \>13

• No history of cystoscopy within 2yrs.

Locations
Other Locations
Republic of Korea
Samsung Medical Center, Sungkyunkwan University School of Medicine
Seoul
Time Frame
Start Date: 2012-08-01
Completion Date: 2025-07-18
Participants
Target number of participants: 442
Authors
Kyu-Sung Lee
Related Therapeutic Areas
Interstitial Cystitis
Prostatectomy
Sponsors
Leads: Samsung Medical Center

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

A Double-Blind, Placebo-Controlled Study to Establish the Safety and Efficacy of Super-Concentrated, Freeze-Dried Aloe Vera in the Management of the Symptoms of Interstitial Cystitis

A Double-Blind, Placebo-Controlled Study to Establish the Safety and Efficacy of Super-Concentrated, Freeze-Dried Aloe Vera in the Management of the Symptoms of Interstitial Cystitis

Who is this study for: Patients with Interstitial Cystitis
Enrollment Status: Recruiting
Publish Date: August 27, 2025
Intervention Type: Other, Drug
Study Drug: Desert Harvest Aloe Vera Capsules
Study Phase: Early Phase 1

A Phase 2b, Open Label, Single-Arm, Multi-Center, Multiple Dose, 14-Day Study to Evaluate the Safety, Efficacy, and Frequency of Intravesical Administration of VNX001 in Acute Treatment of Subjects With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) Who Have an Episode of Acute Bladder Pain of Moderate to Severe Intensity

A Phase 2b, Open Label, Single-Arm, Multi-Center, Multiple Dose, 14-Day Study to Evaluate the Safety, Efficacy, and Frequency of Intravesical Administration of VNX001 in Acute Treatment of Subjects With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) Who Have an Episode of Acute Bladder Pain of Moderate to Severe Intensity

Enrollment Status: Recruiting
Publish Date: September 16, 2025
Intervention Type: Drug
Study Phase: Phase 2

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Peyronie's Disease, Erectile Dysfunction, and Interstitial Cystitis

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Peyronie's Disease, Erectile Dysfunction, and Interstitial Cystitis

Enrollment Status: Recruiting
Publish Date: April 17, 2025
Intervention Type: Biological
Study Phase: Phase 1
View All